Jason Cohen, Editor

About the Author Jason Cohen, Editor

Analyst Sees Over 160% Upside for IntelliPharmaCeutics Intl Inc (USA) Stock

It can be tricky putting a price tag on a biotech company, especially one that …

Juno Therapeutics Inc (JUNO) Spikes on Rumors of Celgene Takeover; Analysts Dive in

Healthcare analysts share thoughts on a potential acquisition of Juno Therapeutics.

Oppenheimer Slashes Price Target on Eiger Biopharmaceuticals Inc (EIGR) Following Clinical Failure in PAH, But Remains Bullish

The company’s future is in serious doubt, but it doesn’t prevent Oppenheimer’s Jay Olson from hitting the ‘buy’ button.

Lipocine Inc. (LPCN): FDA Panel Gives Thumbs Down to TLANDO, What’s Next?

While Lipocine investors run for the hills following negative advisory committee meeting, Canaccord’s Dewey Steadman still sees a light at the end of the tunnel.

Healthcare Stocks Breakout: Pain Therapeutics, Inc. (PTIE), Global Blood Therapeutics Inc (GBT)

Pain Therapeutics to try again with REMOXY NDA Investors love biotech stocks for the lottery …

Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Could Stay Grounded For Now

There’s been much ado about Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA). The generic drug giant …

Global Blood Therapeutics Inc (GBT): Despite Reports of Two Patient Deaths, This Top Analyst Remains Bullish

Why patient deaths don’t necessarily scuttle Global Blood’s chances for voxelotor’s clinical success.

Show More